p210 Bcr–Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia (original) (raw)
- Short Report
- Published: 10 August 1998
Oncogene volume 17, pages 667–672 (1998)Cite this article
- 264 Accesses
- 32 Citations
- Metrics details
Abstract
Chronic myeloid leukaemia (CML) is a clonal disorder of the pluripotent haemopoietic stem cell, the hallmark of which is the constitutively activated Bcr–Abl protein tyrosine kinase. During the initial chronic phase of CML the primitive multipotent leukaemic progenitor cells remain growth factor dependant and are capable of producing terminally differentiated cells. Although the available evidence suggests that Bcr–Abl directly affects signalling pathways involved in controlling the development of primitive haemopoietic progenitors the identification of the specific biological consequences of Bcr–Abl activity in these progenitors has been hampered by the lack of suitable systems modelling CML. By transfecting the multipotent haemopoietic cell line FDCP-Mix with a temperature sensitive mutant of Bcr–Abl we have developed the first working model that mirrors the chronic phase of CML. FDCP-Mix cells expressing Bcr–Abl tyrosine kinase activity remain growth factor dependent and retain their ability to differentiate. Normal neutrophilic cells are formed in response to G-CSF and GM-CSF. In addition, the transfected FDCP-Mix cells grown at the permissive temperature for Bcr–Abl tyrosine kinase activity display enhanced survival and proliferation in low concentrations of growth factor. These findings are consistent with the initial subtle changes seen in CML progenitor cells during the chronic phase and confirm that Bcr–Abl effects are context specific, i.e. they depend on the origin and developmental potential of the transfected cells. This questions the significance of studies in non-haemopoietic and differentiation blocked haemopoietic cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Leukaemia Research Fund Cellular Development Unit, UMIST, Sackville Street, Manchester, M60 1QD
Andrew Pierce, P Jane Owen-Lynch & Anthony D Whetton - Department of Biomolecular Sciences, UMIST, Sackville Street, Manchester, M60 1QD
Elaine Spooncer - Department of Experimental Haematology, Cancer Research Campaign, Paterson Institute for Cancer Research, Christie Hospital, NHS Trust, Manchester, M20 9BX, UK
Elaine Spooncer & T Michael Dexter
Authors
- Andrew Pierce
You can also search for this author inPubMed Google Scholar - P Jane Owen-Lynch
You can also search for this author inPubMed Google Scholar - Elaine Spooncer
You can also search for this author inPubMed Google Scholar - T Michael Dexter
You can also search for this author inPubMed Google Scholar - Anthony D Whetton
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Pierce, A., Owen-Lynch, P., Spooncer, E. et al. p210 Bcr–Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.Oncogene 17, 667–672 (1998). https://doi.org/10.1038/sj.onc.1201969
- Received: 14 November 1997
- Revised: 11 March 1998
- Accepted: 11 March 1998
- Published: 10 August 1998
- Issue Date: 06 August 1998
- DOI: https://doi.org/10.1038/sj.onc.1201969